Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study-Reference-Cited by-同舟云学术

Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study

Published:2016-03-01 Issue:2 Volume:31 Page:277-287
ISSN:1226-3303
Container-title:The Korean Journal of Internal Medicine
language:en
Short-container-title:Korean J Intern Med

Author:

Lee Hae-Young,Chung Wook-Jin,Jeon Hui-Kyung,Seo Hong-Seog,Choi Dong-Ju,Jeon Eun-Seok,Kim Jae-Joong,Shin Joon Han,Kang Seok-Min,Lim Sung Cil,Baek Sang-Hong

Publisher

Korean Association of Internal Medicine

Link

http://kjim.org/upload/kjim-2015-043.pdf

Reference39 articles.

1. Beta-Blockers and Outcome in Heart Failure and Atrial Fibrillation

2. A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry

3. Trends in Hospitalized Acute Myocardial Infarction Patients with Heart Failure in Korea at 1998 and 2008

4. Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure

5. A novel polymorphism in the gene coding for the beta1-adrenergic receptor associated with survival in patients with heart failure

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inotropic Agents: Are We Still in the Middle of Nowhere?;Journal of Clinical Medicine;2024-06-26

2. Mathematical modelling of the influence of ACE I/D polymorphism on blood pressure and antihypertensive therapy;Heliyon;2024-05

3. Mathematical modeling of the influence ofACE I/Dpolymorphism on blood pressure and antihypertensive therapy;2024-01-09

4. β1-adrenergic receptor polymorphisms: a possible genetic predictor of bisoprolol response in acute coronary syndrome;Future Science OA;2023-12

5. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome;Biomedicine & Pharmacotherapy;2023-12